Norgestimate And Ethinyl Estradiol Kit
Product Images NDC 68180-838

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Norgestimate And Ethinyl Estradiol (NDC 68180-838). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ce48faa3 C999 4286 8ee0 66af089d6268 01

An instructional diagram showing a weekly pill pack layout for Norgestimate and ethinyl estradiol. It features circles representing daily doses arranged in rows labeled Week 2 to Week 4, with columns labeled by days Sunday through Saturday. Instructions direct users to start at Sunday unless their period begins on another day. The pack includes an area to place a day label strip and a reminder for monthly self breast exams.*

FDA Label Image

Ce48faa3 C999 4286 8ee0 66af089d6268 02

A forest plot chart showing the risk of breast cancer associated with combined oral contraceptive use across multiple cohort studies from 2002 to 2017. The chart displays effect estimates (odds ratios/relative risks) with confidence intervals for both ever use and current use categories, illustrating variations in risk estimates near or above 1.0.*

FDA Label Image

Ce48faa3 C999 4286 8ee0 66af089d6268 03

Chemical structures of the active ingredients Norgestimate and Ethinyl Estradiol as labeled. The left structure is Norgestimate, and the right is Ethinyl Estradiol, shown as molecular diagrams with carbon rings, hydrogen, and oxygen atoms.*

FDA Label Image

Ce48faa3 C999 4286 8ee0 66af089d6268 04

An illustrative diagram categorizing different birth control methods based on pregnancy rates per 100 women in one year. It shows methods with fewer pregnancies at the top, including implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, and vaginal ring with hormones. Moderate methods like condoms and diaphragm follow, with higher pregnancy rates for no sex during fertile days, spermicide, and withdrawal. The highest pregnancy rate corresponds to no birth control.*

FDA Label Image

Ce48faa3 C999 4286 8ee0 66af089d6268 05

A contraceptive pill day label guide for Norgestimate and ethinyl estradiol, showing a weekly layout from Sunday through Saturday across four rows labeled Week 2, Week 3, and Week 4. Circular placeholders indicate pill positions for each day, with arrows showing the order of intake. Instructions note placing a day label strip if the period starts on a day other than Sunday and remind users of a monthly self breast exam.*

FDA Label Image

Ce48faa3 C999 4286 8ee0 66af089d6268 06

Packaging label for Norgestimate and Ethinyl Estradiol Tablets USP by Lupin Pharmaceuticals, Inc., NDC 68180-838-73. The label indicates multiple tablet strengths: 0.18 mg/0.035 mg, 0.215 mg/0.035 mg, and 0.25 mg/0.035 mg. The package contains 3 blisters of 28 tablets each. The label includes distribution and manufacturing details, with the product manufactured by Lupin Limited in India.*

FDA Label Image

Ce48faa3 C999 4286 8ee0 66af089d6268 07

Label for Norgestimate and Ethinyl Estradiol Tablets USP by Lupin Pharmaceuticals, Inc. The product contains varying strengths of norgestimate and ethinyl estradiol (0.18 mg/0.035 mg, 0.215 mg/0.035 mg, and 0.25 mg/0.035 mg). The label states prescription-only use and includes a blister pack count of 28 tablets. Distributed by Lupin Pharmaceuticals, Inc., manufactured in India. The label includes storage instructions and a caution that the product does not protect against HIV or other sexually transmitted diseases.*

FDA Label Image

Ce48faa3 C999 4286 8ee0 66af089d6268 08

Lidding foil and forming foil/PVC side of a blister pack for Norgestimate and Ethinyl Estradiol Tablets USP from Lupin Pharmaceuticals, Inc. The lidding foil side lists strengths (0.18 mg/0.035 mg, 0.215 mg/0.035 mg, 0.25 mg/0.035 mg) and storage instructions, along with distributor and manufacturer details. The forming foil side is organized with weekly rows and days of the week for tracking daily tablet use, including a reminder for monthly self breast exams.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.